DOTA-Octreotide

Overview

DOTA-Octreotide is composed of chelator DOTA and Octreotide ( HY-P0036 ). DOTA-Octreotide is used for research of cancer , through combination with radioactive elements. DOTA-Octreotide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .

Application

Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Radionuclide-Drug Conjugates (RDCs) | Products > Signaling Pathways > Biochemical Assay Reagents

Product Information

• Catalog No.: HY-P10273
• CAS No.: 209277-09-8
• Molecular Formula: C65H92N14O17S2
• Molecular Weight: 1405.64
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source